Jane Street’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$371K	Buy	+311,829	New	+$371K	﹤0.01%	4060
2024 Q3	–	Sell	-30,714	Closed	-$178K	–	5878
2024 Q2	$178K	Buy	+30,714	New	+$178K	﹤0.01%	5461